Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance

Generated: March 19, 2018

DrugPatentWatch Database Preview

ZOVIA 1/50E-21 Drug Profile

« Back to Dashboard

Which patents cover Zovia 1/50e-21, and when can generic versions of Zovia 1/50e-21 launch?

Zovia 1/50e-21 is a drug marketed by Watson Labs and is included in one NDA.

The generic ingredient in ZOVIA 1/50E-21 is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
Summary for ZOVIA 1/50E-21
Drug patent expirations by year for ZOVIA 1/50E-21
Synonyms for ZOVIA 1/50E-21
(17 alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol, mixt. with (3 beta,17 alpha)-19-norpregn-4-en-20-yne-3,17-diol diacetate
(17alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, mixt. with (3beta,17alpha)-19-norpregn-4-en-20-yne-3,17-diol diacetate
[(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyc
19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17-alpha)-, mixt. with (3-beta,17-alpha)-19-norpregn-4-en-20-yne-3,17-diyl diacetate
19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alph)-, mixt. with (3beta,17alpha)-19-norpregn-4-en-20-yne-3,17-diyl-diacetate
Bisecurin II
Conova 30
DEMULEN 1/35-21
DEMULEN 1/35-28
DEMULEN 1/50-21
DEMULEN 1/50-28
Ethinyl estradiol mixture with ethynodiol diacetate
Ethynodiol Diacetate and Ethinyl Estradiol
Ethynodiol diacetate mixt. with ethynylestradiol
Ethynylestradiol mixt. with ethynodiol diacetate
Kelnor 1/35
Ovamin 30
Ovulen 30
SC 11800 EE
SC-11800 EE
ZOVIA 1/35E-21
ZOVIA 1/35E-28
ZOVIA 1/50E-28

US Patents and Regulatory Information for ZOVIA 1/50E-21

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs ZOVIA 1/50E-21 ethinyl estradiol; ethynodiol diacetate TABLET;ORAL-21 072722-001 Dec 30, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.